Cargando…

Pazopanib and Oral Cyclophosphamide in Women With Platinum-Resistant or -Refractory Epithelial Ovarian Cancer

PURPOSE: Women with recurrent, multiply-treated epithelial ovarian cancer (EOC) have unfavorable prognosis with limited treatment options after failure of platinum-based regimens. We report here a retrospective analysis of women with recurrent, platinum-resistant EOC treated with an oral regimen of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gulia, Seema, Ghosh, Jaya, Bajpai, Jyoti, Rath, Sushmita, Maheshwari, Amita, Shylasree, T.S., Deodhar, Kedar, Thakur, Meenakshi, Gupta, Sudeep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Clinical Oncology 2020
Materias:	Original Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113132/ https://www.ncbi.nlm.nih.gov/pubmed/32228315 http://dx.doi.org/10.1200/JGO.19.00331

Ejemplares similares

Outcomes of Cervical Cancer in HIV-Positive Women Treated With Radiotherapy at a Tertiary Care Center in India
por: Gurram, Lavanya, et al.
Publicado: (2022)

Clinical and Laboratory Characteristics of Patients with Peritoneal Tuberculosis Mimicking Advanced Ovarian Cancer
por: Maheshwari, Amita, et al.
Publicado: (2021)

Knowledge, Attitudes and Practices Towards COVID-19: A Cross-Sectional Survey
por: Poddar, Pabashi, et al.
Publicado: (2022)

Proximal-type epithelioid sarcoma of vulva – Case series of a rare tumor
por: Dash, Biswajit, et al.
Publicado: (2022)

Oligometastatic breast cancer: A mini review
por: Rastogi, Sameer, et al.
Publicado: (2014)

Efficacy and safety of palbociclib and ribociclib in patients with estrogen and/or progesterone receptor positive, HER2 receptor negative metastatic breast cancer in routine clinical practice
por: Rath, Sushmita, et al.
Publicado: (2021)

Pregnancy associated breast cancer (PABC): Report from a gestational cancer registry from a tertiary cancer care centre, India
por: Bajpai, Jyoti, et al.
Publicado: (2021)

Consensus meeting and update on existing guidelines for management of cervical cancer with special emphasis on the practice in developing countries, including India: The expert panel at the 8(th) annual women's cancer initiative Tata Memorial Hospital Conference 2010-11
por: Mahantshetty, Umesh, et al.
Publicado: (2012)

Clinical outcomes of patients treated with template-based high-dose-rate interstitial brachytherapy boost for post-operative recurrent gynecological malignancies: A retrospective analysis
por: Mulye, Gargee, et al.
Publicado: (2022)

Cancer Aging Research Group (CARG) score in older adults undergoing curative intent chemotherapy: a prospective cohort study
por: Ostwal, Vikas, et al.
Publicado: (2021)

National Cancer Grid of India Consensus Guidelines on the Management of Cervical Cancer
por: Chopra, Supriya J., et al.
Publicado: (2018)

Editorial on the topic: Gynecological cancers: A summary of published Indian data
por: Shylasree, T. S., et al.
Publicado: (2016)

CONcurrent ChEmotherapy and RadioTherapy in adjuvant treatment of breast cancer (CONCERT): a phase 2 study
por: Wadasadawala, Tabassum, et al.
Publicado: (2023)

Months and Severity Score (MOSES) in a Phase III trial (PARCER): A new comprehensive method for reporting adverse events in oncology clinical trials
por: Ranjan, Nilesh, et al.
Publicado: (2022)

Outcomes of non-metastatic triple negative breast cancers: Real-world data from a large Indian cohort
por: Bajpai, Jyoti, et al.
Publicado: (2022)

Translation and validation of European Organization for Research and Treatment for Cancer quality of life questionnaire-OV-28 module into Indian languages (Hindi and Marathi) to study quality of life of ovarian cancer patients from a tertiary care cancer center
por: Bajpai, Jyoti, et al.
Publicado: (2018)

Clinical Profile and Outcome of Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer With Brain Metastases: Real-World Experience
por: Bhargava, Prabhat, et al.
Publicado: (2022)

The PACOVAR-trial: A phase I/II study of pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant recurrent, pre-treated ovarian cancer
por: Eichbaum, Michael, et al.
Publicado: (2011)

[(18)F]Fluciclatide PET as a biomarker of response to combination therapy of pazopanib and paclitaxel in platinum-resistant/refractory ovarian cancer
por: Sharma, Rohini, et al.
Publicado: (2019)

Protocol for a phase III randomised trial of image-guided intensity modulated radiotherapy (IG-IMRT) and conventional radiotherapy for late small bowel toxicity reduction after postoperative adjuvant radiation in Ca cervix
por: Chopra, Supriya, et al.
Publicado: (2012)

Successful use of pazopanib for treatment of refractory metastatic hemangiopericytoma
por: Lee, Su Jin, et al.
Publicado: (2014)

Unique challenges and outcomes of young women with breast cancers from a tertiary care cancer centre in India
por: Bajpai, Jyoti, et al.
Publicado: (2021)

Concurrent chemoradiation and brachytherapy alone or in combination with nelfinavir in locally advanced cervical cancer (NELCER): study protocol for a phase III trial
por: Chopra, Supriya, et al.
Publicado: (2022)

Effectiveness and toxicity of metronomic oral cyclophosphamide for recurrent or platinum-refractory ovarian cancer: A meta-analysis
por: Huang, Lili, et al.
Publicado: (2022)

Maintenance therapy with a poly(ADP-ribose) polymerase inhibitor in patients with newly diagnosed advanced epithelial ovarian cancer: individual patient data and trial-level meta-analysis
por: Gulia, S., et al.
Publicado: (2022)

Cytopathological features of scar endometriosis mimicking an adenocarcinoma: A diagnostic pitfall
por: Rekhi, Bharat, et al.
Publicado: (2013)

Taxane Combination Chemotherapy in Breast Cancer: Experience from a Tertiary Cancer Centre in India
por: Bajpai, Jyoti, et al.
Publicado: (2017)

Reply to S. Rastogi et al
por: Gulia, Seema, et al.
Publicado: (2016)

Bevacizumab and oral metronomic cyclophosphamide in platinum-resistant ovarian cancer
por: Pujade-Lauraine, Eric
Publicado: (2013)

Early outcomes of abbreviated multi-fractionated brachytherapy schedule for cervix cancer during COVID-19 pandemic
por: Chopra, Supriya, et al.
Publicado: (2023)

Impact of COVID-19 Pandemic on Gynecological Oncology Care: Glimpse into Association of Gynecological Oncologists of India (AGOI) Perspective
por: Bhandoria, Geetu, et al.
Publicado: (2020)

Gender climate in Indian oncology: national survey report
por: Bajpai, Jyoti, et al.
Publicado: (2020)

Small Cell Carcinoma of Ovary, Hypercalcemic Type (Malignant Rhabdoid Tumor of Ovary) with Loss of SMARCA4 (BRG1) Expression: Report of Two Cases
por: Sahay, Ayushi, et al.
Publicado: (2020)

Severe skin toxicity due to weekly paclitaxel administration
por: Kate, Shruti, et al.
Publicado: (2015)

Intrathecal trastuzumab for leptomeningeal carcinomatosis in patients with human epidermal growth factor receptor 2 positive breast cancer
por: Gulia, Seema, et al.
Publicado: (2016)

BEZ235 (PIK3/mTOR inhibitor) Overcomes Pazopanib Resistance in Patient-Derived Refractory Soft Tissue Sarcoma Cells
por: Kim, Hee Kyung, et al.
Publicado: (2016)

Designing polysaccharide-based antibacterial biomaterials for wound healing applications
por: Chhatri, Amita, et al.
Publicado: (2011)

Para-aortic lymph node involvement in cervical cancer: Implications for staging, outcome & treatment
por: Shylasree, T.S., et al.
Publicado: (2021)

Effects of Pazopanib Monotherapy vs. Pazopanib and Topotecan Combination on Anaplastic Thyroid Cancer Cells
por: Di Desidero, Teresa, et al.
Publicado: (2019)

Infliximab for Idiopathic Deep Cutaneous Vasculitis Refractory to Cyclophosphamide
por: Schafranski, Marcelo Derbli, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_m4rk939beda9g0n5rfsvbuoadc